Performance, transparency, trust

We’re proud of the value we create for all our stakeholders, and strive to communicate our performance in a clear and timely manner. Download the latest reports, or stay up to date on various metrics of our market performance here. If you have any queries not addressed here, please feel free to get in touch with Investor Relations on our Contact page. 

Investors

Observe Medical ASA was listed on Oslo Børs 4 November 2019. Our ambition is to provide shareholders, analysts and investors simultaneous access to accurate, clear and relevant information. We aim to make all our communication to the financial market available on this web site. 

Read our latest regulatory news

Observe Medical ASA – Minutes from Annual General Meeting

Observe Medical ASA has today, June 3, 2022, held the Annual General Meeting. All resolutions were made in accordance with the board's and the nomination committee's proposals. The minutes from the general meeting is attached hereto and will also be available at www.observemedical.com. For further information, please contact:   Rune Nystad, CEO Observe Medical Mobile:…

Read more

Observe Medical ASA: Business update and first quarter 2022 presentation

Oslo, 3 June 2022 – Observe Medical ASA (OSE: OBSRV) (“the Company” or “Observe Medical”) today releases its first quarter results for 2022. Observe Medical has made progress across its medtech platform during the quarter, preparing and strengthening it for growth. The Company has also streamlined the organization and other operational synergies following the acquisition…

Read more

Observe Medical ASA: Notice of Annual General Meeting

Oslo, May 13, 2022 – Observe Medical ASA (OSE:OBSRV): The annual general meeting of Observe Medical ASA will be held on Friday, June 3 2022 at 10:00 (CET). The annual general meeting will be held at Haakon VIIs gate 2, 0161 Oslo for those attending in person and via Lumi for those attending digitally. Voting…

Read more

Financial calendar

  • 25 August 2022

    Quarterly Presentation - Q2 and First Half Report 2022

  • 3 November 2022

    Quarterly Presentation - Q3 2022

The Share

Share performance

Shareholders

Last updated 14 June 2022.

NameNumber of shares% of top 20% of total Country
1INGERØ REITEN INVESTMENT COMPANY AS9,653,680 26.52%18.05%Norway
2NAVAMEDIC ASA4,222,727 11.60%7.89%Norway
3JPB AS2,830,209 7.78%5.29%Norway
4RO, LARS2,670,762 7.34%4.99%Norway
5ELI AS2,072,086 5.69%3.87%Norway
6NORDA ASA1,938,921 5.33%3.62%Norway
7MP PENSJON PK1,701,188 4.67%3.18%Norway
8DnB NOR Bank ASA1,490,225 4.09%2.79%Norway
9ABN AMRO Global Custody Services 1,441,463 3.96%2.69%The Netherlands
10UBS Switzerland AG1,430,398 3.93%2.67%Switzerland
11ALPINE CAPITAL AS867,434 2.38%1.62%Norway
12ARTAL AS827,402 2.27%1.55%Norway
13DnB NOR MARKETS, AKSJEHAND/ANALYSE825,891 2.27%1.54%Norway
14LAPAS AS805,185 2.21%1.51%Norway
15CARNEGIE AS794,778 2.18%1.49%Norway
16NORDNET LIVSFORSIKRING AS665,576 1.83%1.24%Norway
17SOLEGLAD INVEST AS586,668 1.61%1.10%Norway
18SILVERCOIN INDUSTRIES AS574,464 1.58%1.07%Norway
19TAJ HOLDING AS500,847 1.38%0.94%Norway
20TRANBERGKOLLEN INVEST AS500,000 1.37%0.93%Norway
Total number owned by top 20 36,399,904 100.00%68.05%
Total number of shares 53,491,656

Basic share data

Stock Exchange:

Ticker:

First day of listing:

Sector:

Trading Currency:

ISIN:

Number of shares issued:

Nominal value:

Euronext Expand Oslo

OBSRV

4 November 2019

Healthcare

NOK

NO0010865009

19 605 457

NOK 0.26

 

Governance

Nomination committee

The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bård Brath Ingerø (chair) and Grete Hogstad.

The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these.

For nomination committee please contact:
Bård Brath Ingerø, Chair of the Nomination Committee
+47 92 83 33 34 / bbi@reitenco.no

2022

3 June 2022: Minutes from Annual General Meeting 2022

3 June 2022: Represented list

31 May 2022: Board of Directors recommendation for appointment of auditor

31 May 2022: The Nomination Committee recommendation part 2

13 May 2022: Notice of Annual General Meeting on 3 June 2022

13 May 2022: Notice of attendance and proxy form to the Annual General Meeting on 3 June 2022

13 May 2022: The Nomination Committee’s recommendation (part 1)

13 May 2022: Guidelines for determination of salary and other remuneration to executive personnel

13 May 2022: Report on salary and other remuneration to executive personnel year 2021

13 May 2022: VPS – Investor services

13 May 2022: LUMI

13 May 2022: Online guide LUMI (Norsk)

13 May 2022: Online guide LUMI (English)

4 February 2022: Minutes from Extraordinary General Meeting
4 February 2022: Represented list
14 January 2022: Notice of Extraordinary General Meeting on 4 February 2022
14 January 2022: Notice of attendance and proxy form to the Extraordinary General Meeting on 4 February 2022

 

2021

21 May 2021: Minutes from Annual General meeting
30 April 2021: Notice of Annual General Meeting on 21 May 2021

30 April 2021: Notice of attendance and proxy form to the Annual General meeting on 21 May 2021

30 April 2021: The Nomination Committee's recommendation

30 April 2021: Guidelines for determination of salary and other remuneration to executive Personnel

 

2020

30 June 2020: Annual General Meeting

16 June 2020: Extraordinary General Meeting

9 June 2020: Notice of Annual General Meeting on 30 June 2020

9 June 2020: Attendance to the Annual General Meeting on 30 June 2020

9 June 2020: Recommendation by the Nomination Committee

9 June 2020: The Boards declaration on remuneration to executive management

26 May 2020: Notice of Extraordinary General Meeting on 16 June 2020

26 May 2020: Attendance to the Extraordinary General Meeting on 16 June 2020

 

2019

24 October 2019: Extraordinary General Meeting

1 October 2019: Extraordinary General Meeting

5 August 2019: Extraordinary General Meeting

IR contact

Rune Nystad, Chief Executive Officer                                                                         +47 91 62 46 83 / rune.nystad@observemedical.com

Per Arne Nygård, Chief Financial Officer                                                              +47 41 10 43 45 / perarne.nygard@observemedical.com

Sign up for the mailing list